Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve
T cell activation and effector differentiation. They are, likewise, involved in the induction and …

Strategies of improving vaccine targeting ability toward lymph nodes have been attracting
considerable interest in recent years, though there are remaining delivery barriers based on …

Dendritic cells (DCs) have been attracting attention in cancer immunotherapy because of
their role in inducing and modulating effective immune responses. Besides the direct contact …

Dendritic cells (DCs) occupy a central position in the immune system, orchestrating a wide
repertoire of responses that span from the development of self-tolerance to the elicitation of …

In the present study, we assessed the feasibility, toxicity, immunologic response, and clinical
efficacy of vaccination with allogeneic dendritic cell (DC)/tumor fusions in patients with …

Simple Summary Among all intracranial tumors, 31.5% are malignant, and among those,
glioblastomas account for 47%. Recently, our group reported the case of a patient with …

Immune deviation induced by breast cancer may have a role in current failures of dendritic
cell-based immunotherapy. DCs orchestrate immune responses contributing to the pattern of …

CONTEXT: Renal cell carcinoma (RCC) is one of the most immunoresponsive cancers in
humans. Although immunotherapy is currently much less used than in the past, it remains an …

Breast cancer (BC) is the most common malignant neoplasm and the cause of death by
cancer among women worldwide. Its development, including malignancy grade and patient …

Immunotherapy plays a significant role in the management of renal cell carcinoma (RCC)
patients with metastatic disease because RCC is highly resistant to both chemotherapy and …